跳转至内容
Merck

PZ0004

Sigma-Aldrich

伐尼克兰 酒石酸酯

≥98% (HPLC)

别名:

7,8,9,10-四氢-6,10-亚甲基-6H-吡嗪并[2,3-h][3]苯并氮杂卓 酒石酸酯, 酒石酸伐仑克林

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C13H13N3 · C4H6O6
分子量:
361.35
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

powder

顏色

white to beige

溶解度

DMSO: >5 mg/mL

儲存溫度

room temp

SMILES 字串

O[C@H]([C@@H](O)C(O)=O)C(O)=O.C1NC[C@H]2C[C@@H]1c3cc4nccnc4cc23

InChI

1S/C13H13N3.C4H6O6/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1;5-1(3(7)8)2(6)4(9)10/h1-2,4-5,8-9,14H,3,6-7H2;1-2,5-6H,(H,7,8)(H,9,10)/t8-,9+;1-,2-/m.1/s1

InChI 密鑰

TWYFGYXQSYOKLK-CYUSMAIQSA-N

應用

酒石酸伐伦克林已被用于研究其在预脉冲抑制(PPI)下对大鼠感觉运动门控的作用。 它适合用作参考标准品,通过毛细管等速电泳(ITP)和毛细管区带电泳(CZE)在线耦合对尿液样本中的伐伦克林代谢产物进行定量。 它也适用于测试其对大鼠运动和非运动行为缺陷的作用。

生化/生理作用

酒石酸伐伦克林是一种部分α4β2烟碱样受体激动剂和α7完全激动剂。伐伦克林可竞争性地与α4β2受体结合,并在不产生完全尼古丁效应的情况下进行部分刺激,同时阻断尼古丁与受体结合的能力。因此,伐伦克林可阻断尼古丁激活α4β2受体并刺激中枢中脑边缘多巴胺系统的能力,这被认为是吸烟后增强和获得奖赏的神经元机制。

特點和優勢

该化合物在受体分类和信号转导手册的乙酰胆碱受体(烟碱型)页面上有详细描述。想要浏览手册的其他页面, 请单击此处
这种化合物是ADME毒性研究的特色产品。点击此处发现更多特色ADME毒性产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

象形圖

Exclamation markEnvironment

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral - Aquatic Acute 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Anne Jackson et al.
Addiction biology, 22(5), 1316-1328 (2016-07-22)
There is recognition that cognitive problems can contribute to renewed drug taking in former addicts. Our previous work has indicated that current smokers show reduced performance on a probabilistic reversal learning (PRL) task, relative to former smokers. To further explore
On-line column coupled isotachophoresis-capillary zone electrophoresis hyphenated with tandem mass spectrometry in drug analysis: Varenicline and its metabolite in human urine
Pievstansky J, et al.
Analytica Chimica Acta, 826, 84-93 (2014)
Patrick A Randall et al.
Psychopharmacology, 232(14), 2443-2454 (2015-02-07)
Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An important consideration when studying factors that influence drinking/relapse is influence of the pharmacological effects of alcohol on these behaviors. Pre-exposure to alcohol (priming) can increase craving, drinking
Andrea de Bejczy et al.
Alcoholism, clinical and experimental research, 39(11), 2189-2199 (2015-09-29)
Alcohol dependence is a devastating illness affecting a large population, and new pharmacological treatments with good efficacy are greatly needed. One potential candidate is varenicline, a smoking cessation agent with partial agonist action at α4 β2 nicotinic acetylcholine receptors. A
Toshiki Kurosawa et al.
Journal of pharmaceutical sciences, 106(9), 2576-2582 (2017-04-30)
Varenicline is a selective partial α

商品

Sigma-Aldrich offers many products related to nicotinic acetylcholine receptors for your research needs.

Sigma-Aldrich offers many products related to nicotinic acetylcholine receptors for your research needs.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门